GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 128 filers reported holding GOSSAMER BIO INC in Q3 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,296 | +664.6% | 43,583 | +1001.7% | 0.00% | – |
| Q2 2023 | $4,747 | -96.9% | 3,956 | -96.7% | 0.00% | – |
| Q1 2023 | $151,000 | +7484.1% | 119,633 | -87.0% | 0.00% | – |
| Q4 2022 | $1,991 | -99.8% | 917,569 | +1162.1% | 0.00% | – |
| Q3 2022 | $871,000 | +76.0% | 72,701 | +23.2% | 0.00% | – |
| Q2 2022 | $495,000 | -48.3% | 59,004 | -46.5% | 0.00% | – |
| Q1 2022 | $957,000 | +83.0% | 110,313 | +138.6% | 0.00% | – |
| Q4 2021 | $523,000 | -2.2% | 46,230 | +8.7% | 0.00% | – |
| Q3 2021 | $535,000 | +62.1% | 42,545 | +4.8% | 0.00% | – |
| Q2 2021 | $330,000 | +4.8% | 40,613 | +19.6% | 0.00% | – |
| Q1 2021 | $315,000 | +18.4% | 33,947 | +23.5% | 0.00% | – |
| Q4 2020 | $266,000 | -10.4% | 27,482 | +18.9% | 0.00% | – |
| Q3 2020 | $297,000 | +36.2% | 23,122 | +38.0% | 0.00% | – |
| Q2 2020 | $218,000 | +51.4% | 16,754 | +18.5% | 0.00% | – |
| Q1 2020 | $144,000 | -33.9% | 14,139 | +1.5% | 0.00% | – |
| Q4 2019 | $218,000 | -7.6% | 13,926 | -0.9% | 0.00% | – |
| Q3 2019 | $236,000 | +87.3% | 14,059 | +134.5% | 0.00% | – |
| Q2 2019 | $126,000 | +82.6% | 5,995 | +87.5% | 0.00% | – |
| Q1 2019 | $69,000 | – | 3,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
| Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
| Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
| Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
| HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
| Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
| Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
| Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
| Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
| Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |